Cargando…
Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ(1-42) in vitro
Islet transplantation is being considered as an alternative treatment for type 1 diabetes. Despite recent progress, transplant recipients continue to experience progressive loss of insulin independence. Cyanidin-3-O-Glucoside (C3G) has shown to be protective against damage that may lead to post-tran...
Autores principales: | Croden, Jennifer, Silva, Josue Rodrigues, Huang, Wenlong, Gupta, Nancy, Fu, Wen, Matovinovic, Kaja, Black, Mazzen, Li, Xian, Chen, Kunsong, Wu, Yulian, Jhamandas, Jack, Rayat, Gina R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494376/ https://www.ncbi.nlm.nih.gov/pubmed/34614009 http://dx.doi.org/10.1371/journal.pone.0258208 |
Ejemplares similares
-
Chemical Hemisynthesis of Sulfated Cyanidin-3-O-Glucoside and Cyanidin Metabolites
por: Straßmann, Sarah, et al.
Publicado: (2021) -
Anti‐inflammatory activity of cyanidin‐3‐O‐glucoside and cyanidin‐3‐O‐glucoside liposomes in THP‐1 macrophages
por: Hao, Xuefang, et al.
Publicado: (2021) -
Methylation of Cyanidin-3-O-Glucoside with Dimethyl Carbonate
por: Straßmann, Sarah, et al.
Publicado: (2021) -
Effects of Power Ultrasound on Stability of Cyanidin-3-glucoside Obtained from Blueberry
por: Yao, Guang-Long, et al.
Publicado: (2016) -
Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2018)